Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeFirst statedLatest Other Disclosures (2026-10-01): "Advanced"

The Five Pillars and Two Foundations of Medium-Term Management Plan 2028

First written in FY2026. 7 of 10 entries say "Advanced", first in 2026-04-20. Latest entry: 2026-10-01.

10entries
1years
9from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst stated2026-03-23First statedFY2026Advanced2026-09-04 – 2026-10-012026: 102026
Same theme, other companies
Business expansion across five pillars, including pharmaceuticals, drug discovery and global operations, under Medium-Term Management Plan 2028A theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  2. FY2026First statedAnnual report

    「Under Medium-Term Management Plan 2028, we will pursue further growth based on five pillars that will drive group growth and two foundations that support them.」

    国内医療用医薬品、創薬、グローバル、アニマルヘルス、検査・アラウンドピルを5本の柱とし、財務戦略と経営基盤強化を2つの土台とする新たな経営計画の枠組みを示している。
Moved together

"Developing and Utilizing Human Resources Through a New Personnel System and Planned Training" moved the same way as this thread, in the same document, in 2 of its 10 moves.

2★1
  1. ★This thread
  2. 1Developing and Utilizing Human Resources Through a New Personnel System and Planned Training2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview It last moved in the Other Disclosures of 2026-10-01: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.